ID26965A - Obat untuk mencegah dan/atau mengobati kanker payudara, yang mengandung inhibitor aromatase steroid - Google Patents

Obat untuk mencegah dan/atau mengobati kanker payudara, yang mengandung inhibitor aromatase steroid

Info

Publication number
ID26965A
ID26965A IDW20002095A ID20002095A ID26965A ID 26965 A ID26965 A ID 26965A ID W20002095 A IDW20002095 A ID W20002095A ID 20002095 A ID20002095 A ID 20002095A ID 26965 A ID26965 A ID 26965A
Authority
ID
Indonesia
Prior art keywords
breast cancer
aromatase
medicine
prevent
treat breast
Prior art date
Application number
IDW20002095A
Other languages
English (en)
Indonesian (id)
Inventor
Alfred Schmidt
Heinrich Wieland
Original Assignee
S W Patentverwertungs Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8231611&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID26965(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by S W Patentverwertungs Gmbh filed Critical S W Patentverwertungs Gmbh
Publication of ID26965A publication Critical patent/ID26965A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW20002095A 1998-03-18 1999-03-03 Obat untuk mencegah dan/atau mengobati kanker payudara, yang mengandung inhibitor aromatase steroid ID26965A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98104949A EP0943333A1 (fr) 1998-03-18 1998-03-18 Médicament pour la prévention et/ou le traitement du cancer du sein contenant un inhibiteur de la synthèse d'estrogènes

Publications (1)

Publication Number Publication Date
ID26965A true ID26965A (id) 2001-02-22

Family

ID=8231611

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002095A ID26965A (id) 1998-03-18 1999-03-03 Obat untuk mencegah dan/atau mengobati kanker payudara, yang mengandung inhibitor aromatase steroid

Country Status (19)

Country Link
EP (2) EP0943333A1 (fr)
JP (1) JP4920822B2 (fr)
KR (1) KR100778803B1 (fr)
CN (1) CN1168448C (fr)
AT (1) ATE230995T1 (fr)
AU (1) AU751040B2 (fr)
BR (1) BR9908885A (fr)
CA (1) CA2324077C (fr)
CZ (1) CZ292643B6 (fr)
DE (1) DE59904042D1 (fr)
DK (1) DK1063998T3 (fr)
ES (1) ES2190201T3 (fr)
HU (1) HU226105B1 (fr)
ID (1) ID26965A (fr)
IL (1) IL138292A (fr)
PL (1) PL343100A1 (fr)
RU (1) RU2225206C2 (fr)
SK (1) SK285349B6 (fr)
WO (1) WO1999047143A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10042411A1 (de) * 2000-08-30 2002-03-28 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Abgabe von Exemestan
DE10054294A1 (de) * 2000-11-02 2002-05-16 Heinrich Wieland Topische Behandlung bei der Mastalgie
JP4524296B2 (ja) * 2007-03-30 2010-08-11 生化学工業株式会社 発毛促進剤
DE102007032468A1 (de) 2007-07-10 2009-01-15 Brätter, Christian, Dr. Transdermale Therapeutische Systeme, welche den Wirkstoff Anastrozol enthalten
US11850451B2 (en) 2011-01-31 2023-12-26 Lucolas-M.D. Ltd. Cosmetic compositions and methods for improving skin conditions
EP2649994B1 (fr) * 2011-01-31 2017-08-30 LUCOLAS-M.D. Ltd. Combinaisons d'inhibiteurs de l'aromatase et d'antioxydants
WO2012104240A2 (fr) * 2011-01-31 2012-08-09 LUCOLAS-M.D. Ltd Utilisation cosmétique
EP3666276A1 (fr) * 2018-12-14 2020-06-17 dcic Biopharmaceutical Limited Médicament contre la tumeur positive du récepteur d'oestrogene beta (erbeta)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235893A (en) * 1978-05-08 1980-11-25 Brodie Angela M Ester derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for inhibiting estrogen biosynthesis
DE3322285A1 (de) * 1983-06-18 1984-12-20 Schering AG, 1000 Berlin und 4709 Bergkamen 1-alkyl-androsta-1,4-dien-3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
FR2558373B1 (fr) * 1984-01-20 1987-07-03 Mauvais Jarvis Pierre Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee
JPS6345294A (ja) * 1986-04-07 1988-02-26 Shionogi & Co Ltd アロマタ−ゼ阻害ステロイド誘導体
EP0310542B1 (fr) * 1987-10-01 1994-06-08 Schering Aktiengesellschaft Composés antigestagéniques et anti-oestrogéniques pour le traitement des tumeurs dépendant des hormones
FR2656310B1 (fr) * 1989-12-22 1992-05-07 Roussel Uclaf Nouveaux produits sterouides comportant en position 10, un radical thioethyle substitue, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
DE4039559A1 (de) * 1990-12-07 1992-06-11 Schering Ag Funktionalisierte vinylazole, verfahren zu deren herstellung, pharmazeutische praeparate die diese vinylazole enthalten sowie deren verwendung zur herstellung von arzneimitteln
GB9212833D0 (en) * 1992-06-17 1992-07-29 Glaxo Group Ltd Chemical compounds
AU6391894A (en) * 1993-03-16 1994-10-11 Pfizer Inc. Naphthalene derivatives
JPH07215992A (ja) * 1993-12-07 1995-08-15 Teikoku Hormone Mfg Co Ltd ６−又は７−置換アンドロスタ−１，４−ジエン誘導体
DE69519582D1 (de) * 1994-09-14 2001-01-11 Univ Sheffield Kontrolle des haarwuchses
US5780050A (en) * 1995-07-20 1998-07-14 Theratech, Inc. Drug delivery compositions for improved stability of steroids
DE59703511D1 (de) * 1996-03-29 2001-06-13 S W Patentverwaltungs Ges M B Kosmetikum bzw. kosmetikzusammensetzung zur glättung und straffung der haut bei gestörtem unterhaut-binde-fettgewebe, insbesondere bei der "cellulite"
DE69731302T3 (de) * 1996-07-22 2011-01-20 Renovo Ltd. Verwendung von substanzen, die die östrogen wirkung fördern, zur behandlung von wunden

Also Published As

Publication number Publication date
BR9908885A (pt) 2000-11-21
PL343100A1 (en) 2001-07-30
DE59904042D1 (de) 2003-02-20
ATE230995T1 (de) 2003-02-15
CZ20003256A3 (cs) 2001-04-11
JP4920822B2 (ja) 2012-04-18
EP1063998A1 (fr) 2001-01-03
JP2002506823A (ja) 2002-03-05
EP0943333A1 (fr) 1999-09-22
SK285349B6 (sk) 2006-11-03
SK13422000A3 (sk) 2001-05-10
CN1301165A (zh) 2001-06-27
CA2324077C (fr) 2008-07-29
IL138292A0 (en) 2001-10-31
CN1168448C (zh) 2004-09-29
CZ292643B6 (cs) 2003-11-12
DK1063998T3 (da) 2003-05-12
IL138292A (en) 2005-08-31
KR100778803B1 (ko) 2007-11-27
KR20010034603A (ko) 2001-04-25
AU3143499A (en) 1999-10-11
CA2324077A1 (fr) 1999-09-23
WO1999047143A1 (fr) 1999-09-23
HUP0101005A2 (hu) 2001-08-28
HU226105B1 (en) 2008-04-28
RU2225206C2 (ru) 2004-03-10
ES2190201T3 (es) 2003-07-16
AU751040B2 (en) 2002-08-08
EP1063998B1 (fr) 2003-01-15

Similar Documents

Publication Publication Date Title
PL365285A1 (en) Pharmaceutical combinations for the treatment of cancer comprising dioxolane nucleoside analogs
BR0315597A (pt) Processos de baixa dose para tratamento de distúrbios em que a atividade de tnf(alfa)é prejudicial
BR9908592A (pt) Processo para inibir a atividade de 17ß-hidroxiesteróide desidrogenase tipo 5, composição farmacêutica, inibidor de 17ß-hidroxiesteróide desidrogenase tipo 5, processo para inibir 17ß-hidroxiesteróide desidrogenase tipo 3, inibidor de 17ß-hidroxiesteróide desidrogenase tipo 3, processos para tratar, ou reduzir o risco de desenvolver, câncer da próstata, hiperplasia prostática benigna, acne, seborréia, hirsutismo ou alopécia androgênica, sìndrome de ovário policìstico, câncer de mama, endometriose ou leiomioma, para inibir as secreções hormonais testiculares, para tratar puberdade precoce, e, kit
BR9806060A (pt) Composto, composição farmacêutica e processos para tratar um paciente sofrendo de um estado doentio, para inibir o fator xa, e, para inibir a formação de trombina.
DK0595796T3 (da) Fremgangsmåde til behandling af androgen-relaterede sygdomme
BR0207316A (pt) Derivados de epotilona para o tratamento de tumores refratários
MXPA04000654A (es) Terapia dermica usando derivados de fosfato de agente de transferencia de electrones.
BR9509006A (pt) Composiçao para aplicaçao tópica na pele composiçao farmacêutica uso de um inibidor de síntese de colesterol e processo para o tratamento mitigaçao ou prevençao de distúrbios de pele
MY164077A (en) Compositions and uses of et743 for treating cancer
ID26965A (id) Obat untuk mencegah dan/atau mengobati kanker payudara, yang mengandung inhibitor aromatase steroid
SE9803761D0 (sv) Method to avoid increased iridial pigmentation during prostaglandin treatment
HUP9801022A2 (hu) Eljárás aldóz reduktáz inhibítor alkalmazása diabetikus szívizom-betegség megelőzésére vagy megfordítására
AU2003250190A1 (en) Combination of an aromatase inhibitor with a bisphosphonate
GB0020504D0 (en) Therapeutic method
HUP9901505A2 (hu) Dehidroepiandroszteron és aromatázgátlók kombinációja és e kombináció felhasználása férfiak relatív és abszolút androgénhiányának kezelésére szolgáló gyógyszerkészítmények előállítására
DE60030107D1 (de) Vitamin-d derivate zur behandlung des systemischen lupus erythematodes
NZ511559A (en) Use of staurosporine derivatives for treating ocular neovascular diseases
DE69924979D1 (de) Behandlung von chronischen schmerzen
PL367707A1 (en) Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a cox-2 inhibitor and a taxol
BR0111740A (pt) Terapia combinada contra tumores que compreende derivados de distamicina acriloila substituìda e agentes de alquilação
RU94044457A (ru) Применение бензтиофенов для ингибирования гирсутизма и алопеции у женщин
BR0315374A (pt) Compostos orgânicos
AR015537A1 (es) Uso de brinzolamida para la manufactura de un medicamento para tratar o prevenir edema de retina.
NZ337048A (en) Use of N-[1-methyl-(substituted phenyl)ethyl]-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide derivatives to treat prostate cancer
KR930702016A (ko) 골다공증 치료제